(2022-05-09 | OTCQB:ARTH) Arch Therapeutics' Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring
Arch Therapeutics, a Framingham biotechnology company specializing in wound care and biosurgical devices, announced on Monday its AC5 Advanced Wound System would be added to federal contracts.
Renowned Expert Dr. Christopher Gauland Shares Insights on Treating DFUs and Success with AC5® Advanced Wound System FRAMINGHAM, Mass., Dec. 01, 2021 .
Arch Therapeutics Provides Corporate Update forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.